Key result
NGS and genetic testing for hereditary HF and cardiomyopathies improve risk assessment, counseling, and cascade screening.
Why the study?
The genetic contribution to heart failure is heterogeneous and complex, and expanding knowledge of its molecular and genetic pathogenesis is needed to uncover novel therapeutic targets.
Advancements in next-generation sequencing have made genetic testing a routine and valuable tool for the diagnosis, prognosis, and family screening of hereditary heart failure syndromes.
No takes yet. Share an insight, caveat, or question.
May inform risk stratification and family screening in cardiomyopathies; leaves open the need for outcome trials.
Omar Elsaka (2025) conducted a review in Heart Failure. Genetic testing and next-generation sequencing was evaluated. Next-generation sequencing and genetic testing for hereditary heart failure and cardiomyopathies enable improved risk assessment, genetic counseling, and family cascade screening.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: